Toru Okamoto
0000-0003-4000-3102
Publication & Citation Trends
Most Cited Works
Publications
194 total
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies PDF
Cited by 287
OpenAlex
Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2 PDF
Cited by 145
OpenAlex
Arid5a regulates naive CD4+ T cell fate through selective stabilization of Stat3 mRNA PDF
Cited by 109
OpenAlex
Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in <i>p53</i> PDF
Cited by 166
OpenAlex
The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism PDF
Cited by 1,200
OpenAlex
TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1 PDF
Cited by 152
OpenAlex
Ifit1 Inhibits Japanese Encephalitis Virus Replication through Binding to 5′ Capped 2′-O Unmethylated RNA PDF
Cited by 118
OpenAlex
A Cluster of Interferon-γ-Inducible p65 GTPases Plays a Critical Role in Host Defense against Toxoplasma gondii PDF
Cited by 334
OpenAlex
Research Topics
Hepatitis C virus research
(42)
SARS-CoV-2 and COVID-19 Research
(34)
Hepatitis B Virus Studies
(22)
COVID-19 Clinical Research Studies
(20)
Liver Disease Diagnosis and Treatment
(20)
Frequent Co-Authors
Affiliations
Hiroshima University
Jikei University School of Medicine
Memorial Hospital of South Bend
Albert Einstein College of Medicine
Institute for Creation Research